
La Jolla Pharmaceutical Company LJPC
Quarterly report 2022-Q2
added 08-15-2022
La Jolla Pharmaceutical Company Total Inventories 2011-2026 | LJPC
Annual Total Inventories La Jolla Pharmaceutical Company
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.28 M | 6.01 M | 2.21 M | 2.02 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.28 M | 2.02 M | 4.13 M |
Quarterly Total Inventories La Jolla Pharmaceutical Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 8.3 M | 7.11 M | 6.28 M | 6.09 M | 5.48 M | 5.37 M | 6.01 M | 6.01 M | 6.01 M | 6.01 M | 2.21 M | 2.21 M | 2.21 M | 2.21 M | 2.02 M | 2.02 M | 2.02 M | 2.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.3 M | 2.02 M | 4.42 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 327.6 | -1.74 % | $ 42.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.94 | 1.2 % | $ 1.03 B | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.39 | -10.36 % | $ 357 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.19 | -1.18 % | $ 448 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.2 | -1.55 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.52 | 2.15 % | $ 405 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M |